Shenzhen Chipscreen Biosciences Co., Ltd.

SHSE:688321 Stock Report

Market Cap: CN¥7.4b

Shenzhen Chipscreen Biosciences Past Earnings Performance

Past criteria checks 0/6

Shenzhen Chipscreen Biosciences has been growing earnings at an average annual rate of 4.4%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 23.8% per year.

Key information

4.4%

Earnings growth rate

3.8%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate23.8%
Return on equity-4.3%
Net Margin-10.7%
Next Earnings Update26 Apr 2025

Recent past performance updates

Solid Earnings May Not Tell The Whole Story For Shenzhen Chipscreen Biosciences (SHSE:688321)

Apr 05
Solid Earnings May Not Tell The Whole Story For Shenzhen Chipscreen Biosciences (SHSE:688321)

Recent updates

Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) 50% Price Boost Is Out Of Tune With Revenues

Oct 08
Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) 50% Price Boost Is Out Of Tune With Revenues

Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Price In Tune With Revenues

Aug 21
Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Price In Tune With Revenues

We Think Shenzhen Chipscreen Biosciences (SHSE:688321) Has A Fair Chunk Of Debt

Jun 04
We Think Shenzhen Chipscreen Biosciences (SHSE:688321) Has A Fair Chunk Of Debt

Investors Appear Satisfied With Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Prospects As Shares Rocket 26%

Apr 24
Investors Appear Satisfied With Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Prospects As Shares Rocket 26%

Solid Earnings May Not Tell The Whole Story For Shenzhen Chipscreen Biosciences (SHSE:688321)

Apr 05
Solid Earnings May Not Tell The Whole Story For Shenzhen Chipscreen Biosciences (SHSE:688321)

Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Shares Climb 30% But Its Business Is Yet to Catch Up

Mar 06
Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Shares Climb 30% But Its Business Is Yet to Catch Up

Revenue & Expenses Breakdown

How Shenzhen Chipscreen Biosciences makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SHSE:688321 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24656-70384207
30 Jun 24584-108364210
31 Mar 24548103366270
31 Dec 2352489369270
30 Sep 23543168357246
30 Jun 23556192361250
31 Mar 23532-11327180
31 Dec 2253017317164
30 Sep 224904307167
30 Jun 2246310299148
31 Mar 2246026293141
31 Dec 2143022289130
30 Sep 21360-32271126
30 Jun 21342-5236115
31 Mar 2131219202107
31 Dec 202693116492
30 Sep 202313714969
30 Jun 202023113165
31 Mar 201812311554
31 Dec 191741910751
30 Sep 19181378952
30 Jun 19157318445
31 Mar 19142287942
31 Dec 18148318043
31 Dec 17111245438
31 Dec 168554832

Quality Earnings: 688321 is currently unprofitable.

Growing Profit Margin: 688321 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 688321 is unprofitable, but has reduced losses over the past 5 years at a rate of 4.4% per year.

Accelerating Growth: Unable to compare 688321's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 688321 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-2.5%).

Return on Equity

High ROE: 688321 has a negative Return on Equity (-4.28%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 08:24
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen Chipscreen Biosciences Co., Ltd. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhizhong JingChina Merchants Securities Co. Ltd.
Bin WuChina Merchants Securities Co. Ltd.
Yinglan ShuHaitong International Research Limited